15. Neuraminidase inhibitors in chickens, turkeys, and ducks. Extra-label use of drugs in treating food-producing animals for improving rate of weight gain, feed efficiency or other production purposes is prohibited under AMDUCA. A drug (including a bulk drug) may not be mixed into feed for anyuse or at a potency level not specifically permitted by the regulations in 21 CFR Part 558, even if prescribed by a veterinarian. be so severe as to request withdrawal of approval of the drug. In the case of unapproved drugs and devices, reports should be submitted on Form FDA 1932a, Veterinary Adverse Reaction, Lack of Effectiveness, or Product Defect Report , which is available on the FDA website.12 FDA may occasionally need more detailed information about an incident, and the veterinarian may be called by an FDA staff veterinarian. Adverse reactions may also be reported by telephone by calling 888-FDA-VETS (888-332-8387). ● Injunction . An order by a court that requires an individual or corporation to do or refrain from violating or causing violations of the act. ● Criminal prosecution . May be recommended in appropriate cases for violation of Section 301 of the act. Misdemeanor convictions, which do not require proof of intent to violate the act, can result in fines (up to $500,000) and/or imprisonment up to 1 year. Felony convictions, which apply in the case of a second violation or intent to defraud or mislead, can result in fines and/or imprisonment up to 3 years. FDA field offices conduct investigations that may lead to recommendations for enforcement/regulatory action. The action recommended will depend upon the nature of the violation and other factors.
9. Sulfonamide drugs in lactating dairy cattle (except approved use of sulfadimethoxine, sulfabromomethazine, and sulfaethoxypyridazine) 10. Fluoroquinolones 11. Glycopeptides 12. Phenylbutazone in female dairy cattle 20 months of age or older 13. Cephalosporins in cattle, swine, chicken, or turkeys (except for approved uses/formulations) 14. Adamantane in chickens, turkeys, and ducks Reporting adverse drug reactions Users of new animal drug products are encouraged to notify the product’s manufacturer of any unexpected or adverse reactions resulting from the use of that product. The manufacturer is responsible for reporting rates of injury, toxicity, and sensitivity reactions to the FDA, along with unexpected incidence or severity of side-effects associated with use and failure of the drug to exhibit expected pharmacological action. FDA scientists analyze these data to determine whether modifications are needed in the drug’s labeling, dosage level, and so on to mitigate future adverse reactions. In extreme instances, the adverse reactions may Types of FDA regulatory actions The objective of FDA regulatory programs is to ensure compliance with the federal Food, Drug, and Cosmetic Act. Specific enforcement activities include actions to correct and prevent violations, remove violating products or goods from the market, and punish offenders. The range of enforcement activities varies depending on the severity of an infraction. Actions include: ● Warning letter s. Sent to individuals or firms, advising them of violation and requesting a written response outlining corrective actions. ● Seizure . An action brought against an adulterated or misbranded FDA-regulated product to remove specific violating goods from commerce. Interaction with the Food and Drug Administration The Food and Drug Administration is most effective in carrying out its mission under a policy of openness and free communication. Everyone is best served when there is clear understanding of FDA regulations and policies, as well as their administration. The FDA seeks to create confidence in programs that are intended to promote and protect the health and well-being of all. The FDA encourages anyone to contact the agency for assistance, to supply information, or to report a problem with a product. To help direct requests to the proper location for a rapid response, it offers the following guidance: For information on approved drugs, regulations, policies, copies of guidelines, or CVM publications, consult the CVM website.13 For information by mail or to submit suggestions or comments, address a letter to: Center for Veterinary Medicine HFV-1 7519 Standish Place Rockville, MD 20855 CVM can also be contacted via telephone at 240-402-7002 or via email at AskCVM@fda.hhs.gov.
WORKS CITED https://qr2.mobi/Vet-RX
Page 5
Book Code: VFL1526
EliteLearning.com/Veterinarian
Powered by FlippingBook